Brain-gut axis in the modulation of pancreatic enzyme secretion

Journal of Physiology and Pharmacology

Volumn 61, Issue 5, 2010, Pages 523-531

  Jaworek, J ^a   Nawrot Porabka, K ^a   Leja Szpak, A ^a   Konturek, S J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Amylase secretion; Entero pancreatic reflex; Ghrelin; Leptin; Melatonin

Indexed keywords

AMYLASE; CHOLECYSTOKININ; GHRELIN; LEPTIN; MELATONIN; PANCREAS ENZYME; SEROTONIN; TRYPTOPHAN;

ACUTE PANCREATITIS; AMYLASE RELEASE; BRAIN FUNCTION; BRAIN STEM; CHOLECYSTOKININ BLOOD LEVEL; DUODENUM; ENTEROENDOCRINE CELL; ENZYME RELEASE; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INTESTINE INNERVATION; NONHUMAN; PANCREAS FUNCTION; PANCREAS SECRETION; REVIEW; VAGUS NERVE DORSAL NUCLEUS;

AMYLASES; ANIMALS; BRAIN; CHOLECYSTOKININ; DUODENUM; GHRELIN; HUMANS; LEPTIN; MELATONIN; PANCREAS; TRYPTOPHAN;

EID: 78649683407     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Morisset J. Negative control of human pancreatic secretion: physiological mechanisms and factors. Pancreas 2008; 37: 1-12.
2. Li Y. Sensory signal transduction in the vagal primary afferent neurons. Curr Med Chem 2007; 14: 2554-2563.
3. Moran TH. Gut peptides in the control of food intake. Int J Obes (Lond) 2009; 33(Suppl 1): S7-S10.
4. Chaudhri OB, Salem V, Murphy KG, Bloom SR. Gastrointestinal satiety signals. Am J Physiol 2008; 70: 239-255.
5. Kapica M, Puzio I, Kato I, Kuwahara A, Zabielski R. Role of feed-regulating peptides in pancreatic exocrine secretion. J Physiol Pharmacol 2008; 59(Suppl 2): 145-159.
6. Love JA, Yi E, Smith TG. Autonomic pathways regulating pancreatic exocrine secretion. Auton Neurosci 2007; 133: 19-39.
7. Jaworek J, Konturek SJ, Szlachcic A. The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat. Int J Pancreatol 1997; 22: 137-146.
8. Konturek SJ, Pepera J, Zabielski R, et al. Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 2003; 54: 293-317.
9. Niebergall-Roth E, Singer MV. Central and peripheral control of pancreatic exocrine secretion. J Physiol Pharmacol 2001; 4: 523-538.
10. Li Y, Wu X, Zhu J, Yan Y, Owyang C. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathway in the rat. J Physiol 2003; 552: 571-587.
11. Konturek SJ, Zabielski R, Konturek JW, Czarnecki J. Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol 2003; 481: 1-14.
12. Wang Y, Prpic V, Green GM, Reeve JR Jr, Liddle RA. Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC1 cells. Am J Physiol Gastrointest Liver Physiol 2002; 282(1): G16-G22.
13. Williams JA. Regulation of acinar cell function in the pancreas. Curr Opin Gastroenterol 2010; 26: 478-483.
14. Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol Toxicol 2002; 91: 327-332.
15. Owyang C, Logsdon CD. New insight into neurohormonal regulation of pancreatic secretion. Gastroenterology 2004; 127: 957-969.
16. Li Y, Owyang C. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993; 92: 418.
17. Zabielski R. Luminal CCK and its neuronal action on exocrine pancreas. J Physiol Pharmacol 2003; 54(Suppl 4): 81-94.
18. Singer MV, Niebergall-Roth E. Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflex and cholecystokinin. Cell Biol Int 2009; 33: 1-9.
19. Rengman S, Westrom B, Ahren B, Pierzynowski S. Arterial gastroduodenal infusion of cholecystokinin-33 stimulates the exocrine pancreatic enzyme release via an enteropancreatic reflex, without affecting the endocrine insulin secretion in pigs. Pancreas 2009; 38: 213-218.
20. Viard E, Zheng Z, Wan S, Travagli RA. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion. Am J Physiol Gastrointest Liver Physiol 2007; 239: G493-G500.
21. Was S, Coleman FH, Travagli RA. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 2007; 293(2): G484-G492.
22. Li Y, Wu XY, Zhu JX, Owyang C. Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol 2001; 281: G916-G23
23. Li Y, Hao Y, Zhu J, Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal noncholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 2000; 118: 1197-207.
24. Zhu JX, Zhu XY, Owyang C, Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol 2001; 530: 431-442.
25. Mussa BM, Sartor DM, Verberne AJ. Activation of cholecystokinin (CCK1) and serotonin (5-HT3) receptors increases the discharge of pancreatic vagal afferents. Eur J Pharmacol 2008; 601: 198-206.
26. Mussa BM, Sartor DM, Verberne AJ. Dorsal vagal preganglionic neuron: differential responses to CCK1 and 5-HT3 receptor stimulation. Autom Neurosci 2010; 156: 36-43.
27. Moriarty P, Dimaline R, Thompson DG, Dockray GJ. Characterization of cholecystokinin Aand cholecystokinin B receptors expressed by vagal afferent neurons. Neuroscience 1997; 79: 905-913.
28. Li Y, Owyang C. High affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in the rat. Am J Physiol 1997; 273: G679-G685.
29. Glatzle J, Sternini C, Robin C, et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002; 123: 217-226.
30. Cakir B, Kasimay O, Devseren E, Yegen BC. Leptin inhibits gastric emptying in rats: role of CCK receptors and vagal afferent fibers. Physiol Res 2007; 56: 315-322.
31. Sakata I, Yamazaki M, Inoue K, Hayashi Y, Kangawa K, Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neuroci Lett 2003; 342: 183-186.
32. Page AJ, Slattery JA, Milte C, et al. Ghrelin selectively reduces mechanosensotivity of upper gastrointestinal vagal afferents. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1376-G1384.
33. Bubenik GA. Thirty years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol 2008; 59(Suppl 2): 33-51.
34. Huether, G, Poeggler, B, Reimer, A, George, A. Effects of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992; 51: 945-953.
35. Bubenik GA, Pang SF, Hacker RR. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 21: 251-256.
36. Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61: 383-410.
37. Sugden D. Melatonin biosynthesis in the mammalian pineal gland. Experimentia 1989; 45: 922-931.
38. Stefluj J, Horner M, Ghosh M, et al. Gene expression of the key enzymes in melatonin synthesis in extrapineal tissues in the rat. J Pineal Res 2001; 30: 243-247.
39. Caniato R, Filipini R, Piovan A. Melatonin in plants. Adv Exp Med Biol 2003; 527: 593-597.
40. Messner M, Huether G, Lorf T, et al. Presence of melatonin in the human hepatobiliary tract. Life Sci 2004; 69: 543-551.
41. Rodriquez C, Mayo JC, Sainz RM, et al. Regulation of antioxidative enzymes; a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
42. Hardeland R. Melatonin: signaling mechanisms of pleiotrophic agent. Biofactors 2009; 35: 183-192.
43. Lahiri S, Singh P, Singh S, Rashed N, Palit G, Pant KK. Melatonin protects against experimental reflux esophagitis. J Pineal Res 2009; 46: 207-213
44. Jaworek J, Leja-Szpak A, Bonior J, et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34: 40-52.
45. Stebelova K, Anttila K, Manttari S, Saarela SI, Zeman M. Immunohistochemical definition of MT(2) receptors and melatonin in the gastrointestinal tissues of rat. Acta Histochem 2010; 112: 26-33.
46. Jaworek J, Konturek SJ, Tomaszewska R, et al. The circadian rhythm of melatonin modulates the severity of caerulein-induced pancreatitis in the rat. J Pineal Res 2003; 37: 161-170.
47. Jaworek J, Zwirska-Korczala K, Szklarczyk J, et al. Pinealectomy aggravates acute pancreatitis in the rat. Pharmacol Rep 2010; in press.
48. Jaworek J, Konturek SJ, Leja-Szpak A. Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53: 791-804
49. Jaworek J, Nawrot K, Konturek SJ, Leja-Szpak A, Thor P, Pawlik WW. Melatonin and its precursor; L-tryptophan influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36: 155-164.
50. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58(Suppl 6): 65-80.
51. Leja-Szpak A, Nawrot-Porabka K, Jaworek J, et al. Modulation of pancreatic enzyme secretion by melatonin or its precursor: L-tryptophan. Role of CCK and afferent nerves. J Physiol Pharmacol 2004; 55: 33-46.
52. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, et al. Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats. J Physiol Pharmacol 2007; 58(Suppl 6): 81-95.
53. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
54. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tisuue production of leptin: Leptin as a novel placenta-derived hormone in humans. Nat Med 1997; 3: 1029-1033.
55. Bado A, Levasscur S, Attoub S, et al. The stomach is source of leptin. Nature 1998; 394; 790-793.
56. Morton NM, Emilsson V, Liu YL, Cawthorne MA. Leptin action in interstinal cells. J Biol Chem 1998; 26194-26201.
57. Kiefer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta- cells. Biochem Biophys Res Commun 1996; 224; 522-527.
58. Harris DM, Flaningan CL, Go FL, Wu SV. Regulation of cholecystokinin- mediated amylase secretion by leptin in rat pancreatic acinar tumor cell line AR42J. Pancreas 1999; 19: 224-230.
59. Ahren BO, Havel PJ. Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells). Am J Physiol 1999; 277: 959-966.
60. Fehmann HC. Leptin: a potent inhibitor of insulin secretion. Peptides 1997; 18: 1267-1273.
61. Jaworek J, Bonior J, Pierzchalski P, et al. Leptin protects the pancreas from damage indued by caerulein overstimulation by modulating of cytokine production. Pancreatology 2002; 2: 89-99.
62. Konturek PC, Jaworek J, Maniatoglou A, et al. Leptin modulates the inflammatory response in acute pancreatitis. Digestion 2002; 65: 149-160.
63. Matyjek R, Herzig KH, Kato S, Zabielski R. Exogenous lepton inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats. Regul Pept 2003; 114: 15-20.
64. Jaworek J, Bonior J, Konturek SJ, Bilski J, Szlachcic A, Pawlik WW. Role of leptin in the control of postprandial pancreatic secretion. J Physiol Pharmacol 2003; 54: 591-602.
65. Nawrot Porbka K, Jaworek J, Leja-Szpak A, et al. Leptin is able to stimulate pancreatic enzyme secretion via activation of duodeno-pancreatic reflex and CCK release. J Physiol Pharmacol 2004; 55(Suppl 2): 47-57.
66. Kojima M, Hasoda H, Date Y, Nakazato M, Matsou H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
67. Lai KC, Cheng CH, Leung PS. The ghrelin system in ainar cells: localization, expression and regulation in the exocrine pancreas. Pancreas 2007; 35: 1-8.
68. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthetized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
69. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal infant, and adult human lung. J Histochem Cytochem 2002; 50: 1013-1021.
70. Mori K, Yashimoto A, Takaya K, et al. Kidney produces a novel acylated peptide, ghrelin. J Clin Endocrinol Metab 2001; 86: 1464-1469.
71. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 2001; 86: 4284-4291.
72. Arvat E, Di Vito L, Broglio F, et al. Preliminary evidence that ghrelin, the natural GH secretagouge (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000; 23: 493-495.
73. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905-908.
74. Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005; 54: 1638-1649.
75. Cummings DE, Purnell JQ, Frayo SR, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 11714-1719.
76. Peeters TL, Aerssens J, De Smet B, et al. The mouse is a natural knock-out for motilin and for the motilin receptor. Functionally they have been replaced by ghrelin. Neurogastroenterol Motil 2004; 16: 684.
77. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002; 440: 235-254.
78. Broglio F, Prodam F, Me E, et al. Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest 2005; 28(Suppl 5): 23-25.
79. Jacob A, Rajan D, Pathickal B, et al. The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1. Int J Mol Med 2010; 25: 159-164.
80. Warzecha Z, Ceranowicz P, Dembinski A, et al. Therapeutic effect of ghrelin In the course of caerulein-induced acute pancreatitis in rats. J Physiol Pharmacol 2010; 61: 419-427.
81. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 2001; 280: 904-907.
82. Salehi A, Dornonville de la Cour C, Hakanson R, Lundquist I. Effects of ghrelin on insulin and glucagons secretion: a study of isolated pancreatic islets and intact mice. Regul Pept 2004; 118: 143-150.
83. Zhang W, Chen M, Chen Z, Segura BJ, Mullholland MW. Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol 2001; 537: 231-236.
84. Sato N, Kanai S, Takano S, Kurosawa M, Funakoshi A, Miyasaka K. Central administration of ghrelin stimulates pancreatic exocrine secretion via the vagus in conscious rats. Jpn J Physiol 2003; 53: 443-449.
85. Li Y, Wu X, Zhao Y, Chen S, Owyang C. Ghrelin acts on the dorsal vagal complex to stimulate pancreatic protein secretion. Am J Physiol Gastrointest Liver Physiol 2006; 290(6): G1350-G1358.
86. Sugino T, Yamaura J, Yamagishi M, et al. Involvement of cholinergic neurons in the regulation of the ghrelin secretory response to feeding in sheep. Biochem Biophys Res Commun 2003; 304: 308-312.
87. Edholm T, Levin F, Hellstrom PM, Schmidt PT. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004; 121: 25-30.
88. Lai JK, Cheng CH, Ko WH, Leung PS. Ghrelin system in pancreatic AR42J cells its ligand stimulation evokes calcium signaling though ghrelin receptors. Int J Biochem Cell Biol 2005; 37: 887-900.
89. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006; 57: 83-96.
90. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, et al. The effect of luminal ghrelin on pancreatic enzyme secretion in the rat. Regul Pept 2007; 143: 56-63.